Use of the Selective Serotonin 3 Receptor Antagonist Ondansetron in the Treatment of Neuroleptic-Induced Tardive Dyskinesia
Year: 2000
Type: article
Study design: Clinical Trial
Source: American Journal of Psychiatry
Institution: Yehuda Abarbanel Mental Health Center
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2024744942
